Chemoinformaics analysis of 2,2-DIMETHYL-6-CARBOXYCHROMAN-4-ONE
| Molecular Weight | 220.224 | nRot | 1 |
| Heavy Atom Molecular Weight | 208.128 | nRig | 13 |
| Exact Molecular Weight | 220.074 | nRing | 2 |
| Solubility: LogS | -3.356 | nHRing | 1 |
| Solubility: LogP | 2.474 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 31.2495 |
| nHD | 1 | BPOL | 15.5105 |
| QED | 0.787 |
| Synth | 2.2 |
| Natural Product Likeliness | 0.648 |
| NR-PPAR-gamma | 0.146 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.795 |
| MDCK | 0.0000259 |
| BBB | 0.139 |
| PPB | 0.712673 |
| VDSS | 0.282 |
| FU | 0.22163 |
| CYP1A2-inh | 0.098 |
| CYP1A2-sub | 0.113 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.152 |
| CYP2c9-sub | 0.162 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.087 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.105 |
| CL | 3.489 |
| T12 | 0.805 |
| hERG | 0.016 |
| Ames | 0.038 |
| ROA | 0.475 |
| SkinSen | 0.072 |
| Carcinogencity | 0.204 |
| EI | 0.242 |
| Respiratory | 0.198 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.656021 |